|
WO2019014306A2
|
|
Automated processing systems, apparatus, methods and related devices
|
|
WO2018085617A1
|
|
Bispecific antibodies that modulate tlr-4 signaling and uses thereof
|
|
US2017065690A1
|
|
Tscm CELLS AND METHODS FOR USE
|
|
AU2013237703A1
|
|
Use of cd83 in combination therapies
|
|
AU2011203204A1
|
|
CD4+CD25+ regulatory T cells from human blood
|
|
EP2288387A1
|
|
Novel soluble cd83 polypeptides, formulations and methods of use
|
|
WO2009108341A1
|
|
Transient expression of immunomodulatory polypeptides for the prevention and treatment of autoimmune disease, allergy and transplant rejection
|
|
WO2009017743A2
|
|
Improved primers and probes for the amplification and detection of hiv gag, rev and nef polynucleotides
|
|
MX2008015395A
|
|
Use of cd83 in combination therapies.
|
|
AU2007235227A1
|
|
Mature dendritic cell compositions and methods for culturing same
|
|
CN101600445A
|
|
Film the go back to the nest dendritic cell of polypeptide transient transfection and their application
|
|
KR20080106193A
|
|
Dendritic cells transiently transfected with a membrane homing polypeptide and their use
|
|
WO2008018904A2
|
|
Systems and methods for processing samples in a closed container, and related devices
|
|
CA2876618A1
|
|
Devices, systems and related methods suitable for delivery of a liquid medicament stored at cryogenic temperatures
|
|
MX2007012221A
|
|
Dendritic cell compositions and methods.
|
|
EP2251418A1
|
|
Mature dendritic cell compositions and methods for culturing same
|
|
EP2742951A2
|
|
Strain independent amplification of HIV polynucleotides
|
|
WO2006046978A2
|
|
Cationic peptide-mediated transformation
|
|
CN1882603A
|
|
mRNA transfected antigen presenting cells
|
|
AU2003296439A1
|
|
In situ maturation of dendritic cells
|
